Remdesivir treatment for patients with moderate to severe COVID-19.
Turkish journal of medical sciences（2022）
摘要
Remdesivir is a safe and well-tolerated drug and older age, low SpO2 level on admission, tachycardia, and ICU admission are independently associated with increased mortality among patients with moderate/severe COVID-19 receiving remdesivir treatment.
更多查看译文
关键词
COVID-19,antiviral,mortality,remdesivir,treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要